Literature DB >> 2142608

Treatment of sex offenders with Depo-Provera.

T A Kiersch.   

Abstract

Medroxyprogesterone acetate (MPA) is capable of reducing male testosterone blood levels with a corresponding reduction in sexual interest and activity. An attempt to evaluate its effectiveness with court committed sexual offenders was made with eight subjects each serving as his own control by alternating Depo-Provera injections for 16 weeks with saline injections for a corresponding 16 weeks. This paper reports the results of this study and the conclusions that appear to be appropriate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142608

Source DB:  PubMed          Journal:  Bull Am Acad Psychiatry Law        ISSN: 0091-634X


  4 in total

Review 1.  The aggressive patient/inmate: beyond denial.

Authors:  G J Maier
Journal:  Psychiatr Q       Date:  1999

2.  Medroxyprogesterone acetate and dihydrotestosterone induce coronary hyperreactivity in intact male rhesus monkeys.

Authors:  Rajesh G Mishra; R Kent Hermsmeyer; Koichi Miyagawa; Philip Sarrel; Barry Uchida; Frank Z Stanczyk; Kenneth A Burry; D Roger Illingworth; Frank J Nordt
Journal:  J Clin Endocrinol Metab       Date:  2005-03-15       Impact factor: 5.958

Review 3.  Pharmacological interventions for those who have sexually offended or are at risk of offending.

Authors:  Omer Khan; Michael Ferriter; Nick Huband; Melanie J Powney; Jane A Dennis; Conor Duggan
Journal:  Cochrane Database Syst Rev       Date:  2015-02-18

4.  Changed processing of visual sexual stimuli under GnRH-therapy--a single case study in pedophilia using eye tracking and fMRI.

Authors:  Kirsten Jordan; Peter Fromberger; Helge Laubinger; Peter Dechent; Jürgen L Müller
Journal:  BMC Psychiatry       Date:  2014-05-17       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.